Stock UNICHEMLAB UNICHEM LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Unichem Laboratories Limited NSE India S.E.

Equities

UNICHEMLAB

INE351A01035

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 05:13:50 02/05/2024 pm IST 		5-day change 1st Jan Change
585.4 INR -0.39% Intraday chart for Unichem Laboratories Limited +1.62% +44.21%
29/03 Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024 CI
27/03 Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down MT

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 20,123 13,697 10,656 21,776 18,330 20,351
Enterprise Value (EV) 1 6,011 5,715 6,268 19,829 18,094 21,638
P/E ratio 1.02 x -57.5 x -17.7 x 63.4 x 55.6 x -10.1 x
Yield 1.75% 2.06% 2.64% 1.29% 1.54% -
Capitalization / Revenue 2.46 x 1.16 x 0.88 x 1.76 x 1.44 x 1.52 x
EV / Revenue 0.73 x 0.48 x 0.52 x 1.61 x 1.42 x 1.61 x
EV / EBITDA -4.56 x -8.32 x -11.4 x 23.6 x 24.2 x -45.1 x
EV / FCF -2.4 x -1.17 x -2 x -9.72 x -5.18 x -29.2 x
FCF Yield -41.6% -85.6% -49.9% -10.3% -19.3% -3.42%
Price to Book 0.75 x 0.52 x 0.42 x 0.85 x 0.7 x 0.84 x
Nbr of stocks (in thousands) 70,337 70,383 70,406 70,406 70,406 70,406
Reference price 2 286.1 194.6 151.4 309.3 260.4 289.0
Announcement Date 03/07/18 29/06/19 04/08/20 02/07/21 12/07/22 30/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 8,180 11,800 12,106 12,351 12,698 13,430
EBITDA 1 -1,317 -687.3 -551.6 838.6 747 -480.2
EBIT 1 -1,823 -1,362 -1,298 72.76 -109 -1,556
Operating Margin -22.28% -11.54% -10.72% 0.59% -0.86% -11.58%
Earnings before Tax (EBT) 1 -1,298 -599.1 -482.1 514.8 219.7 -1,764
Net income 1 25,449 -238 -601.8 343.2 330.6 -2,022
Net margin 311.11% -2.02% -4.97% 2.78% 2.6% -15.06%
EPS 2 280.6 -3.383 -8.550 4.875 4.680 -28.72
Free Cash Flow 1 -2,501 -4,889 -3,131 -2,041 -3,495 -740.5
FCF margin -30.57% -41.43% -25.86% -16.52% -27.52% -5.51%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 5.000 4.000 4.000 4.000 4.000 -
Announcement Date 03/07/18 29/06/19 04/08/20 02/07/21 12/07/22 30/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 1,288
Net Cash position 1 14,112 7,981 4,388 1,948 236 -
Leverage (Debt/EBITDA) - - - - - -2.681 x
Free Cash Flow 1 -2,501 -4,889 -3,131 -2,041 -3,495 -740
ROE (net income / shareholders' equity) -7.11% -0.96% -2.34% 1.35% 1.28% -8%
ROA (Net income/ Total Assets) -4.83% -2.68% -2.58% 0.15% -0.21% -2.99%
Assets 1 -5,26,722 8,870 23,346 2,36,723 -1,56,394 67,714
Book Value Per Share 2 381.0 372.0 360.0 363.0 372.0 346.0
Cash Flow per Share 2 94.70 28.00 32.10 11.00 15.50 26.10
Capex 1 1,596 1,943 3,862 2,878 1,270 443
Capex / Sales 19.51% 16.47% 31.9% 23.3% 10% 3.3%
Announcement Date 03/07/18 29/06/19 04/08/20 02/07/21 12/07/22 30/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.35% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.68% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.09% 326B
ABBVIE INC. Stock AbbVie Inc.
+2.76% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.07% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. UNICHEMLAB Stock
  4. UNICHEMLAB Stock
  5. Financials Unichem Laboratories Limited